文献速递免疫规划

以葡聚糖颗粒包装的荚膜组织胞浆菌碱性提取物接种可在小鼠中赋予保护性免疫

Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.
PubMed 文献 · Vaccine · 2018-05-02

研究将荚膜组织胞浆菌酵母相碱性提取物封装于葡聚糖颗粒,免疫C57BL/6小鼠后鼻内感染,第7天和第14天肺和脾的CFU数降低,并抵御致死性攻击;肺部干扰素-γ和白细胞介素-17增加,Th1和Th17细胞增多,中和这两种细胞因子削弱疫苗效果。

要点

  • 葡聚糖颗粒包装的荚膜组织胞浆菌碱性提取物可降低小鼠鼻内感染后第7天和第14天肺和脾的CFU数。
  • 该疫苗可保护小鼠抵御致死性攻击,并增加肺部干扰素-γ和白细胞介素-17。
  • 中和干扰素-γ或白细胞介素-17可削弱疫苗有效性,保护依赖Th1和Th17应答。

核心结论

  • 以葡聚糖颗粒包装的荚膜组织胞浆菌碱性提取物以干扰素-γ和白细胞介素-17依赖的方式赋予小鼠保护性免疫。

研究设计与样本

  • 研究制备荚膜组织胞浆菌酵母相碱性提取物并封装于葡聚糖颗粒,免疫C57BL/6小鼠后进行鼻内感染攻击。

主要发现

  • 免疫组小鼠鼻内感染后第7天和第14天肺和脾的CFU数较对照组降低。
  • 该疫苗可保护小鼠抵御致死性攻击。
  • 在CFU数与对照组相似的时点,疫苗受者肺部干扰素-γ和白细胞介素-17数量增加。
  • 疫苗免疫小鼠肺和引流淋巴结中Th1和Th17细胞生成较对照组增加。
  • 中和干扰素-γ或白细胞介素-17可削弱疫苗有效性。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文指出,发现该混合物中介导保护性免疫的单个蛋白或少数蛋白将是预防组织胞浆菌病努力中的重大进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection with the dimorphic fungus, Histoplasma capsulatum, occurs world-wide, but North and South America are regions of high endemicity. Interventions to mitigate exposure and consequent disease are limited to remediating a habitat harboring the fungus. The development of a vaccine to prevent infection or lessen its severity is an important advance in disease prevention. Accordingly, we prepared an alkaline extract from the yeast phase of Histoplasma and encased it in glucan particles that act as an adjuvant and delivery vehicle. Immunization of C57BL/6 mice with this encapsulated extract decreased the number of CFUs in lungs and spleens at days 7 and 14 following intranasal infection. Moreover, this vaccine conferred protection against a lethal challenge with the fungus. Cytokine assessment in lungs at a time when the CFUs were similar between controls and vaccinated groups revealed increased quantities of interferon-γ and interleukin-17 in vaccine recipients. This finding was supported by increased generation of both Th1 and Th17 cells in lungs and draining lymph nodes of vaccinated mice compared to controls. Neutralization of interferon-γ or interleukin-17 blunted the effectiveness of vaccination. To identify the proteins comprising this extract, liquid chromatography tandem mass spectrometry was performed. Thus, an H. capsulatum alkaline extract packaged in glucan particles confers protection in an interferon-γ and interleukin-17-dependent manner. Discovery of a single protein or a few proteins in this admixture that mediate protective immunity would represent significant progress in efforts to prevent histoplasmosis.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Deepe GS, Buesing WR, Ostroff GR, et al. Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice. Vaccine. 2018. PMID: 29729993. doi:10.1016/j.vaccine.2018.04.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。